EyeSense was founded in 2006 as a spin off from CIBA Vision, a subsidiary of the Novartis Company.

In 2007 already successful clinical trials were being performed with the eye sensor prototypes. Further studies and product improvements carried through until 2010. The Eye sensor is currently at advanced prototype stage. Since 2010 we have concentrated our development on the continuous glucose monitoring system. In 2011 and 2012 successful studies were conducted for the CGM System. Since 2013 EyeSense is working on developing the CGM System to maturity.